English |  Español                                                                       
 
Home Products Contacts About DOSA
            (*) Next launching

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deflazacort - Cordefla EN.pdf

 

Name of the product: CORDEFLA 6  (*) 

Active ingredient: Deflazacort 6 mg

Dosage form: tablets

 

Name of the product: CORDEFLA 30 (*)

Active ingredient: Deflazacort 30 mg

Dosage form: tablets

 

Dispensing requirements: Rx only

Argentine Industry

 

Composition:

 

CORDEFLA 6:

Each tablet contains deflazacort 6 mg, corn starch, microcrystalline cellulose pH 200, lactose DT, and magnesium stearate.

 

CORDEFLA 30:

Each tablet contains deflazacort 30 mg, corn starch, microcrystalline cellulose pH 200, lactose DT, and magnesium stearate.

 

Indications:

 

Deflazacort is a glucocorticoid with anti-inflamatory and immunosuppressant properties. It is indicated for the treatment of endocrine, dermatological, allergic, respiratory, haematological, neoplastic (leukaemia, lymphoma, multiple myeloma), renal, gastrointestinal and neurological conditions.

 

Therapeutic action:

 

Glucocorticoid with anti-inflammatory and immunosuppressant properties.

 

Storage:

 

Keep at temperature below 25º C in the marketed packing.

 

Marketed presentations:

 

CORDEFLA 6:

Packs containing 10 and 20 tablets.

Packs containing 500 tablets, for use in hospital.

 

CORDEFLA 30:

Packs containing 10 and 20 tablets.

Packs containing 500 tablets, for use in hospital.

 

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 52515

 

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist

 

 

Laboratorio DOSA S.A. - Girardot 1369 (C1427AKC) Ciudad de Buenos Aires - Argentina